In 2023, driven by personal loss, I joined LMS with the goal of accelerating research on cancer medication. Having witnessed the devastating impact of this disease on loved ones, I am personally motivated to pursue innovative therapies that can save lives and prevent families from experiencing the same heartbreak.

Under the guidance of Dr. Fets and Professor Lenhard, I have the opportunity to combine the best of both pharmacology and computational biology at LMS lab. I am confident that the cutting-edge research being conducted at LMS aligns perfectly with my aspirations to make a meaningful difference in the fight against cancer. This is why I decided to join LMS.